Search research articles
Contact Us
Filters
Showing results (11-20 of 64) with videos related to
Page
of 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2005
Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer
Fairooz F Kabbinavar, Julie Hambleton, Robert D Mass, et al.
Endocrine Pathology
|
November 18, 2024
Progression of Low-Grade Neuroendocrine Tumors (NET) to High-Grade Neoplasms Harboring the NEC-Like Co-alteration of RB1 and TP53
Nancy M Joseph, Sarah E Umetsu, Grace E Kim, et al.
JCO Precision Oncology
|
June 23, 2022
Checkpoint Inhibitor Immunotherapy to Treat Temozolomide-Associated Hypermutation in Advanced Atypical Carcinoid Tumor of the Lung
Fangdi Sun, James P Grenert, Lisa Tan, et al.
Psycho-Oncology
|
August 19, 2003
Couples therapy at end of life
David C Mohr, Patricia J Moran, Carolynn Kohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2002
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer
Fairooz Kabbinavar, Herbert I Hurwitz, Louis Fehrenbacher, et al.
JCO Precision Oncology
|
February 1, 2022
Complete Response and Immune-Mediated Adverse Effects With Checkpoint Blockade: Treatment of Mismatch Repair-Deficient Colorectal Neuroendocrine Carcinoma
Julia Whitman, Adel Kardosh, Luis Diaz, et al.
Abdominal Imaging
|
March 31, 2015
Simultaneous (68)Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor
Thomas A Hope, Miguel Hernandez Pampaloni, Eric Nakakura, et al.
JCO Oncology Practice
|
May 1, 2020
Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk
Emil Lou, Shaalan Beg, Emily Bergsland, et al.
Cancers
|
June 2, 2021
The Immunotherapy Landscape in Adrenocortical Cancer
Guillaume J Pegna, Nitin Roper, Rosandra N Kaplan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 12, 2025
Burdens of Gastroenteropancreatic Neuroendocrine Neoplasm by Diverse Race and Ethnicities- A Rigorous Structural Equation Modeling
Alan Paciorek, Claire Mulvey, Meg McKinley, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 64) with videos related to
Sort By:
Page
of 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2005
Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer
Fairooz F Kabbinavar, Julie Hambleton, Robert D Mass, et al.
Endocrine Pathology
|
November 18, 2024
Progression of Low-Grade Neuroendocrine Tumors (NET) to High-Grade Neoplasms Harboring the NEC-Like Co-alteration of RB1 and TP53
Nancy M Joseph, Sarah E Umetsu, Grace E Kim, et al.
JCO Precision Oncology
|
June 23, 2022
Checkpoint Inhibitor Immunotherapy to Treat Temozolomide-Associated Hypermutation in Advanced Atypical Carcinoid Tumor of the Lung
Fangdi Sun, James P Grenert, Lisa Tan, et al.
Psycho-Oncology
|
August 19, 2003
Couples therapy at end of life
David C Mohr, Patricia J Moran, Carolynn Kohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2002
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer
Fairooz Kabbinavar, Herbert I Hurwitz, Louis Fehrenbacher, et al.
JCO Precision Oncology
|
February 1, 2022
Complete Response and Immune-Mediated Adverse Effects With Checkpoint Blockade: Treatment of Mismatch Repair-Deficient Colorectal Neuroendocrine Carcinoma
Julia Whitman, Adel Kardosh, Luis Diaz, et al.
Abdominal Imaging
|
March 31, 2015
Simultaneous (68)Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor
Thomas A Hope, Miguel Hernandez Pampaloni, Eric Nakakura, et al.
JCO Oncology Practice
|
May 1, 2020
Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk
Emil Lou, Shaalan Beg, Emily Bergsland, et al.
Cancers
|
June 2, 2021
The Immunotherapy Landscape in Adrenocortical Cancer
Guillaume J Pegna, Nitin Roper, Rosandra N Kaplan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 12, 2025
Burdens of Gastroenteropancreatic Neuroendocrine Neoplasm by Diverse Race and Ethnicities- A Rigorous Structural Equation Modeling
Alan Paciorek, Claire Mulvey, Meg McKinley, et al.
Page
of 7